Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Features

Calculation of Lost Profits Damages in Patent Cases Image

Calculation of Lost Profits Damages in Patent Cases

Michael M. Carlson

Part one of this series, published last month, reviewed the current state of the law governing the availability of lost profits damages in patent infringement cases. This final installment addresses the calculation of these damages based on diverted sales.

Recovery of Damages for Use of the Invention Claimed in a Published Patent Application Image

Recovery of Damages for Use of the Invention Claimed in a Published Patent Application

Jitendra Malik, Ph.D. & Michael S. Connor

In last month's issue, we discussed the prerequisites for a patentee to recover a royalty for his provisional rights. Provisional rights are intended to give a patent applicant interim protection for the disclosure of his invention from the date on which a patent application is published through the date of patent issuance. In the absence of provisional rights, infringement of the invention as published in the patent application would leave the patentee without redress for infringement while the application is being prosecuted. Without provisional rights, the patentee can stop infringement when a patent issues, but cannot seek compensation for prior infringement of the published patent application. <br>To address the vulnerabilities of a patent applicant prior to issuance of a patent, Congress enacted the Provisional Rights subsection as part of the American Inventors Protection Act of 1999. Notable among a patent applicant's provisional rights is the right to assess a "reasonable royalty" for use of an invention as claimed in the published application. 35 U.S.C. &sect;154(d) (2000). As the Director of the USPTO commented, "In practice, this would serve as a brake on potential infringers ... from blatantly infringing because they know once the patent is issued, they're liable [for infringing the patent application]." Sabra Chartrand, <i>A New Law Removes Some Secrecy From the Applications</i>, N.Y. Times, Dec. 4, 2000, at C6. <br>Last month's installment of this article described the prerequisites required to raise a patentee's provisional rights. First, the USPTO must grant a patent from the patent application. Second, the accused infringer must have actual notice of the published patent application. Third, provisional rights are only available if the invention as claimed in the patent is substantially identical to the invention as claimed in the published patent application. Last month's installment also described the nuances of each requirement, and also explored unsettled legal questions relating to each. This month's article explores the interplay between the publication requirement and the Provisional Rights Subsection.

March issue in PDF format Image

March issue in PDF format

ALM Staff & Law Journal Newsletters

&#133;

Features

Patent Reissue after Eggert: Reclaiming the Ring Image

Patent Reissue after Eggert: Reclaiming the Ring

Michael Messinger & Lori Gordon

When considering a broadening reissue application, patent owners often confront a recurring issue: Can a limitation added or argued during prosecution of an original patent to gain allowance over prior art later be broadened during reissue? Recent developments in case law at the Federal Circuit Court of Appeals and U.S. Patent and Trademark Office ("USPTO") suggest a way to permissibly broaden such limitations through reissue and still avoid recapture. We call it reclaiming the ring.

'Add-on Patents': Innovation or Sham? Image

'Add-on Patents': Innovation or Sham?

Teresa J. Welch, Ph.D.

Some recent estimates suggest that by 2007 brand name pharmaceutical companies will lose more than $80 billion in drug sales because of patent term expirations. Patent term expirations, of course, usher the entry of generic drugs into the marketplace. On average, the market share for branded products decreases by 15% to 30% when a first generic version reaches the market, and as much as 75% to 90% when subsequent generics launch. Such significant losses provide incentive to extend patent life and maximize the period of market exclusivity for a patented drug.

You're Not Exhausted: U.S. Patent Rights Are Not Exhausted By Foreign Sales Image

You're Not Exhausted: U.S. Patent Rights Are Not Exhausted By Foreign Sales

Matthew W. Siegal & Angie M. Hankins

Your client International Marketers, Inc. (IMI) owns U.S. and foreign patents for an improved football. IMI wants to license the patent and make direct sales of identical balls around the world, while making its own sales to the U.S. market. However, IMI knows that the price consumers will pay for its football is much higher in the United States than elsewhere. IMI is concerned that footballs sold by it and its licensees to distributors outside the United States might be purchased by third parties and imported back into the United States at a price below what it hopes to charge distributors in the United States.

Cameo Clips Image

Cameo Clips

ALM Staff & Law Journal Newsletters

Recent cases in entertainment law.

Courthouse Steps Image

Courthouse Steps

ALM Staff & Law Journal Newsletters

Recently filed cases in entertainment law, straight from the steps of the Los Angeles Superior Court.

Features

Counsel Concerns Image

Counsel Concerns

ALM Staff & Law Journal Newsletters

Attorney-Client Privilege<br>Personal Jurisdiction Over Lawyers

<b>Decision of Note: </b>Music Downloader Loses Argument Based on Fair Use Image

<b>Decision of Note: </b>Music Downloader Loses Argument Based on Fair Use

ALM Staff & Law Journal Newsletters

The U.S. District Court for the Northern District of Illinois ruled that a defendant who engaged in the unauthorized downloading of sound recordings from the Internet didn't have a viable fair-use defense.

Need Help?

  1. Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
  2. Need other assistance? email Customer Service or call 1-877-256-2472.

MOST POPULAR STORIES